Pharmaceutical Product Information

Pegasys® (peginterferon alfa-2a)

In May 2022, Roche transferred the sponsorship and management of supply, customer support, medical information, regulatory services, sales and marketing of Pegasys to Echo Therapeutics Pty Ltd in Australia. The current Consumer Medicine Information (CMI) and Product Information (PI) for Pegasys are available from the Therapeutic Goods Administration (TGA) website at: https://www.ebs.tga.gov.au/